Literature DB >> 1323691

Polyprotein processing in cis and in trans by hepatitis A virus 3C protease cloned and expressed in Escherichia coli.

S A Harmon1, W Updike, X Y Jia, D F Summers, E Ehrenfeld.   

Abstract

To determine the P3 region protein-processing sites cleaved by the hepatitis A virus 3C protease, a nested set of constructs containing a portion of 3A (3A* [the asterisk denotes an incomplete protein]), 3B and 3C and various amounts of 3D, fused in frame to Escherichia coli TrpE-coding sequences under control of the tryptophan promoter, was made. Additional plasmids that encoded a portion of 2C (2C*) and the P3 proteins, including complete or incomplete 3D sequences, were constructed. After induction, E. coli containing these recombinant plasmids produced high levels of fusion proteins as insoluble aggregates. 3C-mediated cleavage products were identified by comparison of expression with a matching set of plasmids, containing an engineered mutation in 3C. Cleavage products were detected by immunoblot analyses by using antisera against the TrpE protein, against 3D*, and against 3CD*. Scissile bonds were determined by N-terminal amino acid sequencing of the proteins formed by cleavage. The results showed that when a portion of 2C was present, the primary cleavage by the 3C protease was between 2C and 3A, and the cleavage site was QG, as predicted by J. I. Cohen, J. R. Ticehurst, R. H. Purcell, A. Buckler-White, and B. M. Baroudy, J. Virol. 61:50-59, 1987. Very little further cleavage of the released P3 protein was detected. When the fusion protein contained no 2C and included only 3A*-to-3D sequences, efficient cleavage occurred between 3B and 3C, at the QS pair, also as predicted by Cohen et al. (J. Virol. 61:50-59, 1987). The latter proteins were also cleaved between 3C and 3D, but less efficiently than between 3B and 3C. Extracts of bacteria expressing proteins from 3A* to 3D also cleaved a radiolabelled hepatitis A virus substrate containing VP1*2ABC* sequences in trans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323691      PMCID: PMC289077     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Propagation of human hepatitis A virus in cell culture in vitro.

Authors:  P J Provost; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

2.  Preparative elution of proteins blotted to Immobilon membranes.

Authors:  B Szewczyk; D F Summers
Journal:  Anal Biochem       Date:  1988-01       Impact factor: 3.365

Review 3.  Viral proteinases.

Authors:  H G Kräusslich; E Wimmer
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Replicative events in hepatitis A virus-infected MRC-5 cells.

Authors:  J De Chastonay; G Siegl
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

5.  Biophysical and biochemical characterization of hepatitis A virus.

Authors:  A G Coulepis; S A Locarnini; E G Westaway; G A Tannock; I D Gust
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

6.  Classification of hepatitis A virus as enterovirus type 72 and of hepatitis B virus as hepadnavirus type 1.

Authors:  J L Melnick
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

7.  Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses.

Authors:  J I Cohen; J R Ticehurst; R H Purcell; A Buckler-White; B M Baroudy
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

8.  Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region.

Authors:  G D Parks; G M Duke; A C Palmenberg
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

9.  Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture.

Authors:  J I Cohen; J R Ticehurst; S M Feinstone; B Rosenblum; R H Purcell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

10.  ompT encodes the Escherichia coli outer membrane protease that cleaves T7 RNA polymerase during purification.

Authors:  J Grodberg; J J Dunn
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

View more
  20 in total

Review 1.  Structural aspects of activation pathways of aspartic protease zymogens and viral 3C protease precursors.

Authors:  A R Khan; N Khazanovich-Bernstein; E M Bergmann; M N James
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Full-length genome of wild-type hepatitis A virus (DL3) isolated in China.

Authors:  Guo-Dong Liu; Ning-Zhu Hu; Yun-Zhang Hu
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

3.  Determinants in 3Dpol modulate the rate of growth of hepatitis A virus.

Authors:  Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

4.  Stable growth of wild-type hepatitis A virus in cell culture.

Authors:  Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 5.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

6.  Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation.

Authors:  J Graff; J Cha; L B Blyn; E Ehrenfeld
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

7.  The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition.

Authors:  E M Bergmann; S C Mosimann; M M Chernaia; B A Malcolm; M N James
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Structural basis for host membrane remodeling induced by protein 2B of hepatitis A virus.

Authors:  Laia Vives-Adrián; Damià Garriga; Mònica Buxaderas; Joana Fraga; Pedro José Barbosa Pereira; Sandra Macedo-Ribeiro; Núria Verdaguer
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

9.  Theiler's murine encephalomyelitis virus contrasts with encephalomyocarditis and foot-and-mouth disease viruses in its functional utilization of the StopGo non-standard translation mechanism.

Authors:  G Loughran; J E Libbey; S Uddowla; M F Scallan; M D Ryan; R S Fujinami; E Rieder; J F Atkins
Journal:  J Gen Virol       Date:  2012-10-24       Impact factor: 3.891

10.  Hepatitis A virus (HAV) packaging size limit.

Authors:  Krishnamurthy Konduru; Siham M Nakamura; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-11-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.